Study of Cell-mediated Response in Mice by HPV16 L1 Virus-like Particles Expressed in Saccharomyces cerevisiae |
Woo, Mi-Kyung
(College of Pharmacy, Chung Ang University)
Hur, Sook-Jin (Korea Food and Drug Administration) Park, Sue-NIe (National Institute of Toxicological Research) Kim, Hong-Jin (College of Pharmacy, Chung Ang University) |
1 | Emeny, R. T., C. M. Wheeler, K. U. Jansen, W. C. Hunt, T. M. Fu, J. F. Smith, S. MacMullen, M. T. Esser, and X. Paliard. 2002. Priming of human papillomavirus type 11- specific humoral and cellular immune responses in collegeaged women with a virus-like particle vaccine. J. Virol. 76: 7832-7842 DOI |
2 | Kim, H. C., H. J. Kim, W. B. Choi, and S. W. Nam. 2006. Inulooligosaccharide production from inulin by Saccharomyces cerevisiae strain displaying cell-surface endoinulinase. J. Microbiol. Biotechnol. 16: 360-367 과학기술학회마을 |
3 | Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assay. J. Immunol. Methods 65: 55-63 DOI ScienceOn |
4 | Ha, C. H., K. H. Lim, S. H. Jang, C. W. Yun, H. D. Paik, S. W. Kim, C. W. Kang, and H. I. Chang. 2006. Immuneenhancing alkali-soluble glucans produced by wild-type and mutant Saccharomyces cerevisiae. J. Microbiol. Biotechnol. 16: 576-583 과학기술학회마을 |
5 | Marais, D., J. A. Passmore, J. Maclean, R. Rose, and A. L. Williamson. 1999. A recombinant human papillomavirus (HPV) type 16 L1-vaccinia virus murine challenge model demonstrates cell-mediated immunity against HPV viruslike particles. J. Gen. Virol. 80: 2471-2475 DOI |
6 | Parkin, D. M., P. Pisani, and J. Ferlay. 1999. Estimates of worldwide incidence of 25 major cancers in 1990. Int. J. Cancer 80: 827-841 DOI ScienceOn |
7 | Bosch, F. X., M. M. Manos, N. Munoz, M. Sherman, A. M. Jansen, J. Peto, M. H. Schiffman, V. Moreno, R. Kurman, and K. V. Shah. 1995. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J. Natl. Cancer Inst. 87: 796-802 DOI ScienceOn |
8 | Kim, H. Y., J. O. Yang, and G. E. Ji. 2005. Effect of bifidobacteria on production of allergy-related cytokines from mouse spleen cells. J. Microbiol. Biotechnol. 15: 265-268 과학기술학회마을 |
9 | Sasagawa, T., P. Pushko, G. Steers, S. E. Gschmeissner, M. A. Hajibagheri, J. Finch, L. Crawford, and M. Tommasino. 1995. Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe. Virology 206: 126-135 DOI ScienceOn |
10 | Lee, J. S., J. Yu, H. J. Shin, Y. S. Kim, J. K. Ahn, C. K. Lee, H. Y. Poo, and C. J. Kim. 2005. Expression of hepatitis C virus structural protein in Saccharomyces cerevisiae. J. Microbiol. Biotechnol. 15: 767-771 과학기술학회마을 |
11 | Inglis, S., A. Shaw, and S. Koenig. 2006. Chapter 11: HPV vaccines: Commercial research and development. Vaccine 24Suppl3: S99-S105 DOI ScienceOn |
12 | Volpers, C., P. Schirmacher, R. E. Streeck, and M. Sapp. 1994. Assembly of the major and the minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells. Virology 200: 504-512 DOI ScienceOn |
13 | Walboomers, J. M., M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer, K. V. Shah, P. J. Snijders, J. Peto, C. J. Meijer, and N. Munoz. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189: 12-19 DOI ScienceOn |
14 | Dupuy, C., D. Buzoni-Gatel, A. Touze, P. Le Cann, D. Bout, and P. Coursaget. 1997. Cell-mediated immunity induced in mice by HPV 16 L1 virus-like particles. Microb. Pathog. 22: 219-225 DOI ScienceOn |
15 | Finkelman, F. D., J. Holmes, I. M. Katona, J. F. Urban, M. P. Beckmann, L. S. Park, K. A. Schooley, R. L. Coffman, T. R. Mosmann, and W. E. Paul. 1990. Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8: 303-333 DOI ScienceOn |
16 | Hagensee, M. E., N. Yaegashi, and D. A. Galloway. 1993. Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J. Virol. 67: 315-322 |
17 | Kim, E., H. Y. Poo, M. H. Sung, and C. J. Kim. 2005. Mature HIV-like particles produced from single Semliki Forest virus-derived expression vector. J. Microbiol. Biotechnol. 15: 1229-1239 과학기술학회마을 |
18 | Lowe, R. S., D. R. Brown, J. T. Bryan, J. C. Cook, H. A. George, K. J. Hofmann, W. M. Hurni, J. G. Joyce, E. D. Lehman, H. Z. Markus, M. P. Neeper, L. D. Schultz, A. R. Shaw, and K. U. Jansen. 1997. Human papillomavirus type 11 (HPV-11) neutralizing antibodies in the serum and genital mucosal secretions of African green monkeys immunized with HPV-11 virus-like particles expressed in yeast. J. Infect. Dis. 176: 1141-1145 DOI ScienceOn |
19 | Kirnbauer, R., F. Booy, N. Cheng, D. R. Lowy, and J. T. Schiller. 1992. Papillomavirus L1 major capsid protein selfassembles into virus-like particles that are highly immunogenic. Proc. Natl. Acad. Sci. USA 89: 12180-12184 |
20 | Rose, R. C., W. Bonnez, R. C. Reichman, and R. L. Garcea. 1993. Expression of human papillomavirus type 11 L1 protein in insect cells: In vivo and in vitro assembly of viruslike particles. J. Virol. 67: 1936-1944 |
21 | Khajuri, A., A. Gupta, F. Malik, S. Singh, J. Singh, B. D. Gupta, K. A. Suri, P. Suden, V. K. Srinivas, K. Ella, and G. N. Qazi. 2007. A new vaccine adjuvant (BOS 2000), a potent enhancer mixed Th1/Th2 immune responses in mice immunized with HBsAg. Vaccine 25: 4586-4594 DOI ScienceOn |
22 | Kim, S. N., H. S. Jeong, S. N. Park, and H. J. Kim. 2007. Purification and immunogenicity study of human papillomavirus type 16 L1 protein in Saccharomyces cerevisiae. J. Virol. Methods 139: 24-30 DOI ScienceOn |
23 | Palker, T. J., J. M. Monteiro, M. M. Martin, C. Kakareka, J. F. Smith, J. C. Cook, J. G. Joyce, and K. U. Jansen. 2001. Antibody, cytokine and cytotoxic T lymphocyte responses in chimpanzees immunized with human papillomavirus viruslike particles. Vaccine 19: 3733-3743 DOI ScienceOn |
24 | Pisani, P., D. M. Parkin, F. Bray, and J. Ferlay. 1999. Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer 83: 18-29 |